£4.0M
Parkwalk Advisors led the round with a £3.5m investment to fund new pediatric capabilities for the Censeo platform.
Psyomics
Psyomics develops artificial intelligence software to improve mental health assessment and diagnosis.
£7.9MTotal raised
Psyomics is a Cambridge spinout that develops artificial intelligence software to streamline mental health assessments and triage. Its platform Censeo builds detailed patient profiles to guide clinical treatment pathways.
Categories
Founders
SB
Sabine Bahn
Laboratory Director
Daniel Cowell
Co-founder
Daniel is the chief operating officer at Momentous Therapeutics. He previously served as chief executive officer at Psyomics and chief operating officer at Horizon Discovery.
Investors
- £4.0M
- £2.4M
- £1.5M
Funding history
£2.4M
Parkwalk led the Series B financing, with participation from Meltwind, Newable Ventures and BGF, to widen access to the Censeo platform.
£1.5M
Parkwalk led the follow-on investment round to support the market launch of the company's mental health assessment tool.